Venture Planning Group Market Research Reports

Title published price

2019-2023 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape

By Venture Planning Group

Complete report $2,750.  DataPack (test volumes, sales forecasts, supplier shares) $1,750.  The report is available by section, market segment, and can be custom-tailored to your specifi ...

04-Feb-2019 $2750

2019-2023 U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape

By Venture Planning Group

Complete report $1,850.  DataPack (test volumes, sales forecasts, supplier shares) $1,200.  The report is available by section, market segment, and can be custom-tailored to your specifi ...

04-Feb-2019 $1850

2019-2023 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape

By Venture Planning Group

Complete report $1,850.  DataPack (test volumes, sales forecasts, supplier shares) $1,200.  The report is available by section, market segment, and can be custom-tailored to your specifi ...

04-Feb-2019 $1850

2019-2023 Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape

By Venture Planning Group

Complete report $2,450.  DataPack (test volumes, sales forecasts, supplier shares) $1,450.  The report is available by section, market segment, and can be custom-tailored to your specifi ...

04-Feb-2019 $2450

2019-2023 Italy Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Landscape

By Venture Planning Group

Complete report $1,850.  DataPack (test volumes, sales forecasts, supplier shares) $1,200.  The report is available by section, market segment, and can be custom-tailored to your specifi ...

04-Feb-2019 $1850

2019-2023 Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape

By Venture Planning Group

Complete report $1,850.  DataPack (test volumes, sales forecasts, supplier shares) $1,200.  The report is available by section, market segment, and can be custom-tailored to your specifi ...

04-Feb-2019 $1850

2019-2023 France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape

By Venture Planning Group

Complete report $1,850.  DataPack (test volumes, sales forecasts, supplier shares) $1,200.  The report is available by section, market segment, and can be custom-tailored to your specifi ...

04-Feb-2019 $1850

2019-2023 Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: France, Germany, Italy, Spain, UK--Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape

By Venture Planning Group

Complete report $4,850.  DataPack (test volumes, sales forecasts, supplier shares) $2,850.  The report is available by country, section, market segment, and can be custom-tailored to you ...

04-Feb-2019 $4850

2019-2023 Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Testing: US, Europe, Japan--Supplier Shares, Country Segment Forecasts, Emerging Technologies, Competitive Landscape

By Venture Planning Group

Complete report $8,750.  DataPack (test volumes, sales forecasts, supplier shares) $5,400.  The report is available by country, section, market segment, and can be custo ...

04-Feb-2019 $8750

2019 Emerging Clinical Chemistry and Immunodiagnostic Technologies, and Strategic Profiles of Leading Suppliers

By Venture Planning Group

This 145-page report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays,  IT, dry chemistry, biosensors, robotics, m ...

04-Feb-2019 $3850

2019 Emerging Coagulation Testing Technologies and Strategic Profiles of Leading Suppliers

By Venture Planning Group

This 124-page report provides assessments of such technologies as chromogenic substrates, monoclonal and polyclonal antibodies, immunoassays, IT, molecular diagnostics, and their potential applications for coagulation testing.The report als ...

04-Feb-2019 $3850

2019 Emerging Cancer Diagnostic Technologies and Strategic Profiles of Leading Suppliers

By Venture Planning Group

This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diag ...

04-Feb-2019 $3850

2019 Emerging Blood Typing, Grouping and NAT Screening Technologies, and Strategic Profiles of Leading Suppliers

By Venture Planning Group

This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components ...

04-Feb-2019 $3850

2019 Cancer Diagnostic Instrumentation: Tumor Marker Testing Analyzers and Strategic Profiles of Leading Suppliers

By Venture Planning Group

This 119-page report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing. The report also presents strategic assessments of current and emerging su ...

04-Feb-2019 $3850

2019 Blood Bank Instrumentation: Transfusion Diagnostic Testing Analyzers and Strategic Profiles of Leading Suppliers

By Venture Planning Group

This 68-page report reviews current instrumentation technologies, and compares features of leading transfusion diagnostic automated and semi-automated analyzers.The report also presents strategic assessments of current and emerging supplier ...

04-Feb-2019 $3850

2019 Molecular Diagnostic Instrumentation and Strategic Profiles of Leading Suppliers

By Venture Planning Group

This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating NAT methods in order to facilitate their penetration into the routine clinical laboratory market.  Some instrumentation is ...

04-Feb-2019 $3850

2019 Infectious Disease Testing Instrumentation: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Latest Microbiology Analyzers and Strategic Profiles of Leading Suppliers

By Venture Planning Group

This 86-page report reviews major analyzers used for microbiology testing, including their operating characteristics, features and selling prices. The report also presents strategic assessments of leading microbiology market players and eme ...

04-Feb-2019 $3850

2019 Hemostasis Diagnostic Instrumentation and Strategic Profiles of Leading Suppliers

By Venture Planning Group

This 71-page report reviews current instrumentation technologies, and compares features of leading automated and semiautomated hemostasis diagnostic analyzers.The report also presents strategic assessments of current and emerging suppliers ...

04-Feb-2019 $2850

2019 Hematology and Flow Cytometry Instrumentation: Latest Analyzers and Strategic Profiles of Leading Suppliers

By Venture Planning Group

This 65-page report reviews current instrumentation technologies, and compares features of leading hematology and flow cytometry analyzers.The report also presents strategic assessments of current and emerging suppliers of hematology and fl ...

04-Feb-2019 $3850

2019 Flow Cytometry Instrumentation: Latest Analyzers and Strategic Profiles of Leading Suppliers

By Venture Planning Group

This 40-page report reviews current instrumentation technologies, and compares features of leading flow cytometry analyzers.The report also presents strategic assessments of current and emerging suppliers of hematology and flow cytometry an ...

04-Feb-2019 $2850